ATF - Bureau of Alcohol, Tobacco, Firearms and Explosives

01/14/2026 | Press release | Distributed by Public on 01/14/2026 12:14

Kansas City Man Indicted for Distribution of Controlled Substances and Illegal Sales of Firearms (DOJ)

KANSAS CITY, Mo. - German Alvarez-Rubio, 28, of Kansas City, Mo., was indicted by a federal grand jury for conspiracy and distribution of cocaine, methamphetamine, and psilocybin as well as firearms offenses.

Alvarez-Rubio made his first appearance in federal court after his arrest on January 12, 2026.

The indictment alleges that on July 22, 2025, the Alvarez-Rubio distributed cocaine. On July 29, 2025, Alvarez-Rubio distributed cocaine and methamphetamine and illegally sold ten firearms. On August 19, 2025, Alvarez-Rubio distributed methamphetamine, cocaine, and psilocybin (mushrooms) and illegally possessed a machinegun.

The charges contained in this indictment are simply accusations, and not evidence of guilt. Evidence supporting the charges must be presented to a federal trial jury, whose duty is to determine guilt or innocence.

This case is being prosecuted by Assistant U.S. Attorney Heather Siegele. It was investigated by the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) and Homeland Security Investigations (HSI).

Operation Take Back America

This case is part of Operation Take Back America, a nationwide initiative that marshals the full resources of the Department of Justice to repel the invasion of illegal immigration, achieve the total elimination of cartels and transnational criminal organizations (TCOs), and protect our communities from the perpetrators of violent crime.

ATF - Bureau of Alcohol, Tobacco, Firearms and Explosives published this content on January 14, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 14, 2026 at 18:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]